No Data
Spot information for individual stocks (1)
Sumitomo Pharma <4506.T> hits the upper limit. The core operating profit Financial Estimates (consolidated) for the fiscal year ending March 2025 have been raised. Sales of the advanced prostate cancer treatment "Orgovyx" have increased. Komatsu Wall <7949.T> hits the upper limit in buy orders. The consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is 4.1 billion yen (a 12% increase compared to the previous period). The level of Dividends will be raised from 3.0% as the lower limit of DOEs (Return on Equity) to a target of 6%. SMS <2175.T> has risen for nine consecutive days. The consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is...
Stocks that moved and those that were traded in the front market.
* Komatsu Wall <7949> 1780 - The significant increase in the dividend plan raises the appeal of the yield. * Sumitomo Pharma <4506> 787 +100 The substantial upward revision beyond expectations has an impact. * Square Enix HD <9684> 8121 +993 3D Investment emerged as a major shareholder. * S.M.S <2175> 1360 +168 The forecast of double-digit profit growth this period and the strengthening of shareholder returns are well received. * Genky Drug Stores <9267> 3630 +42
Kandenko, Amano ETC (Additional) Rating
Upgraded - Bullish Code Stock Name Securities Company Previous Change After----------------------------------------------------------------- <4626> Taiyo HD Morgan S "Equal W" "Over W" <8308> Resona HD Nomura "Neutral" "Buy" Target Price Change Code Stock Name Securities Company Previous Change After-------------------------------------
The Nikkei average is up by about 20 yen, with the top gainers among the selected stocks being Sumitomo Pharma, TOTO, NEC, ETC.
On the 30th at around 11 AM, the Nikkei Stock Average was trading around 35,860 yen, up about 20 yen compared to the previous trading day. At 9:09 AM, it reached 36,023.24 yen, up 183.25 yen. After the buying frenzy, there were moments of retraction as there were few clues, and the exchange rate was also moving in the direction of a stronger yen. Afterward, it remained in a range near the previous trading day's closing price. Among the stocks listed in the Nikkei Average, Sumitomo Pharma <4506.T> and TOTO <5332> ranked high in terms of price increase percentage.
Kanematsu, Marubeni, ETC [List of stock materials from the newspaper]
*Kanematsu <8020> IT staff increased by 2.5 times, expanding orders for virtual Servers, and planning to acquire an information-related company within the fiscal year (Nikkan Kogyo, Front Page) -○ *ORIX <8591> sold 8 companies to NEC Group for 18 billion yen (Nikkan Kogyo, Page 3) -○ *Sony Group Corp <6758> has no concrete plans for separating the Semiconductors business (Nikkan Kogyo, Page 3) -○ *Marubeni <8002> accelerates investment in consumer Business, establishing a new company through corporate discovery (Nikkan Kogyo, Page 4) -○ *Toyota Tsusho <8015> invests in a US electrolytic iron manufacturer to secure raw materials for 'green Steel'.
NEC's Full-Year Profit Rises 18%
